ATE279928T1 - Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben - Google Patents

Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben

Info

Publication number
ATE279928T1
ATE279928T1 AT00954693T AT00954693T ATE279928T1 AT E279928 T1 ATE279928 T1 AT E279928T1 AT 00954693 T AT00954693 T AT 00954693T AT 00954693 T AT00954693 T AT 00954693T AT E279928 T1 ATE279928 T1 AT E279928T1
Authority
AT
Austria
Prior art keywords
biologically active
active agent
controlled release
production
same
Prior art date
Application number
AT00954693T
Other languages
English (en)
Inventor
Manja Ahola
Eija Saeilynoja
Jukka Salonen
Risto Penttinen
Antti Yli-Urpo
Original Assignee
Bioxid Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioxid Oy filed Critical Bioxid Oy
Application granted granted Critical
Publication of ATE279928T1 publication Critical patent/ATE279928T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT00954693T 1999-08-25 2000-08-22 Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben ATE279928T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI19991806A FI19991806A7 (fi) 1999-08-25 1999-08-25 Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus
PCT/FI2000/000710 WO2001013924A1 (en) 1999-08-25 2000-08-22 Novel compositions for controlled release of a biologically active agent, and the preparation thereof

Publications (1)

Publication Number Publication Date
ATE279928T1 true ATE279928T1 (de) 2004-11-15

Family

ID=8555195

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954693T ATE279928T1 (de) 1999-08-25 2000-08-22 Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben

Country Status (11)

Country Link
US (1) US7112339B1 (de)
EP (1) EP1206268B1 (de)
JP (1) JP2003507427A (de)
AT (1) ATE279928T1 (de)
AU (1) AU6705400A (de)
CA (1) CA2379982A1 (de)
DE (1) DE60015151T2 (de)
DK (1) DK1206268T3 (de)
ES (1) ES2230141T3 (de)
FI (1) FI19991806A7 (de)
WO (1) WO2001013924A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ573300A0 (en) * 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
CA2442284C (en) * 2001-04-04 2009-10-06 Delsitech Oy Biodegradable carrier and method for preparation thereof
US20030231984A1 (en) * 2002-05-07 2003-12-18 Bright Frank V. Method to rapidly prepare and screen formulations and compositions containing same
DE10249874A1 (de) * 2002-10-25 2004-05-06 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Antiadhäsive Beschichtung zur Ausrüstung von Wundverbänden
WO2004081222A2 (en) 2003-03-14 2004-09-23 Sol-Gel Technologies Ltd. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
EA008771B1 (ru) 2003-07-31 2007-08-31 Сол-Джел Текнолоджиз Лтд. Микрокапсулы, заполненные активными ингредиентами, и способ их приготовления
CA2555179A1 (en) * 2004-02-27 2005-09-09 Delsitech Oy Method for preparing adjustably bioresorbable sol-gel derived sio2
GB0420016D0 (en) 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
EP2431089A1 (de) 2005-08-02 2012-03-21 Sol-Gel Technologies Ltd. Metalloxidbeschichtung von wasserunlöslichen Inhaltsstoffen
AU2008211554B2 (en) 2007-02-01 2013-12-19 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
FI20070174A0 (fi) * 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
US11458105B2 (en) 2008-12-04 2022-10-04 International Flavors & Fragrances Inc. Hybrid fragrance encapsulate formulation and method for using the same
US9763861B2 (en) 2008-12-04 2017-09-19 International Flavors & Fragrances Inc. Stable, flowable silica capsule formulation
KR101070345B1 (ko) 2009-07-03 2011-10-06 서울대학교산학협력단 생체활성인자가 포함된 유무기 혼성 복합 코팅층, 생체 이식용 임플란트 및 그 제조방법
ES2919933T3 (es) * 2011-03-18 2022-07-29 Int Flavors & Fragrances Inc Microcápsulas producidas a partir de precursores de sol-gel combinados y método de producción de las mismas
JP6199883B2 (ja) 2011-12-05 2017-09-20 インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ 医療用オルガノゲルプロセス及び組成物
CN113842362A (zh) 2012-11-14 2021-12-28 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
EP3651756B1 (de) 2017-07-12 2025-09-03 Sol-Gel Technologies Ltd. Zusammensetzungen mit verkapseltem tretinoin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804318A (en) * 1995-10-26 1998-09-08 Corvita Corporation Lubricious hydrogel surface modification
JP3488965B2 (ja) * 1996-05-21 2004-01-19 日本山村硝子株式会社 ゾル−ゲル法による独立膜の製造方法
DE69733889T3 (de) 1996-05-29 2009-10-22 Delsitech Oy Lösliche oxide für biologische anwendungen
WO2000050349A2 (en) * 1999-02-22 2000-08-31 Bioxid Oy Biodegradable ceramic fibres from silica sols

Also Published As

Publication number Publication date
AU6705400A (en) 2001-03-19
FI19991806L (fi) 2001-02-26
JP2003507427A (ja) 2003-02-25
WO2001013924A1 (en) 2001-03-01
EP1206268A1 (de) 2002-05-22
FI19991806A7 (fi) 2001-02-26
DK1206268T3 (da) 2005-01-10
DE60015151T2 (de) 2006-02-16
DE60015151D1 (de) 2004-11-25
EP1206268B1 (de) 2004-10-20
US7112339B1 (en) 2006-09-26
CA2379982A1 (en) 2001-03-01
WO2001013924A8 (en) 2001-11-01
ES2230141T3 (es) 2005-05-01

Similar Documents

Publication Publication Date Title
ATE279928T1 (de) Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben
DE60030777D1 (de) Durch ein sol-gel verfahren hergestellte bioaktive silicafasern und zugehörige verfahren und anwendungen
MXPA04001741A (es) Telas dispersables en agua sensibles al ion, un metodo y el uso de las mismas.
AU8841801A (en) Switchable tackiness coating compositions for ophthalmic implants
ATE477311T1 (de) Beschichtungszusammensetzung und verfahren
ES2142123T3 (es) Derivados de organosiloxanilo de alcanodiol-monovinil-eteres, proceso para su preparacion, su modificacion y su empleo como aditivos para barnices.
WO2003017990A3 (en) Ophthalmic composition comprising an ascomycin
EE05091B1 (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
DE60112330D1 (en) Pyrazolopyridinderivate
WO2003017924A3 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
PL331322A1 (en) Application of new glass compositions for making glass dental pillars and supporting pillars and method iof making such glass pillars
EP1545605B8 (de) Zusammensetzung zur impfung
DE50206761D1 (de) Fluorhaltige copolymere, deren herstellung und verwendung
WO2003062443A3 (en) Novel substituted alkane compounds and uses thereof
MXPA04003755A (es) Endoprotesis vasculares.
BR0213246A (pt) Composição aquosa, método para tratar um substrato poroso, artigo, e, composição resistente a mancha
BRPI0511574A (pt) composição, método para depositar um poliéster de açúcar sobre um substrato, e, uso de uma composição
ATE355596T1 (de) Dielektrische keramikkomposition, verfahren zur herstellung eines keramikkondensators, verwendung eines keramischen dielektrikums, und keramikkondensator
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
WO2002070638A3 (en) Essential oil from.coleus forskohlii, production process and use as antimicrobial agent
DE60114598D1 (de) Verfahren zur herstellung von hydrierten aromatischen polymerzusammensetzungen
ATE442361T1 (de) Verfahren zur herstellung kristalliner formen von orlistat
ATE278729T1 (de) Verfahren zur herstellung von organosilizium- zusammensetzungen
NO20054088L (no) Vandig beleggingsmidler
WO2003070159A3 (en) Novel coumarin and chromene compounds and methods of treating or preventing viral infections

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1206268

Country of ref document: EP

REN Ceased due to non-payment of the annual fee